-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LHeK79GOmDpdxWuqf6KfAOQxpYfwMl5C+lO8m1eVZR1hmoKebtrDMf/kA2AYN6Ym SvHvM+oGOTvREz+lM3jkCQ== 0000891618-04-000114.txt : 20040114 0000891618-04-000114.hdr.sgml : 20040114 20040114163300 ACCESSION NUMBER: 0000891618-04-000114 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040114 ITEM INFORMATION: Other events FILED AS OF DATE: 20040114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14758 FILM NUMBER: 04525230 BUSINESS ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 BUSINESS PHONE: 5104000700 MAIL ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 8-K 1 f95643e8vk.htm FORM 8-K DATED 1/14/2004 Questcor Pharmaceuticals, Inc. Form 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 14, 2004

QUESTCOR PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)
         
California   0-20772   33-0476164
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (I.R.S. Employer Identification No.)
         
3260 Whipple Road Union City, California
   94587
(Address of Principal Executive Offices)
   (Zip Code)

Registrant’s telephone number, including area code: (510) 400-0700

 

Item 5. Other Events.
SIGNATURE

Table of Contents

This Current Report on Form 8-K is filed by Questcor Pharmaceuticals, Inc., a California corporation (the “Company”), in connection with the matters described herein.

Item 5. Other Events.

The Company’s Board of Directors (the “Board”) has created the designation of Lead Director and has appointed Brian C. Cunningham, a current member of the Board, to serve as Lead Director until the Company’s next annual meeting of shareholders. As Lead Director, Mr. Cunningham will be responsible for coordinating the activities of the Company’s independent directors, presiding over regularly scheduled meetings of the Board and acting with the Company’s Chairman, President and Chief Executive Officer Charles J. Casamento as a liaison between the Board and investors to provide general board leadership.

 

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
Dated: January 14, 2004        
         
    QUESTCOR PHARMACEUTICALS, INC.
         
    By:   /s/ CHARLES J. CASAMENTO
       
        Charles J. Casamento
        Chairman, President and Chief Executive Officer

  -----END PRIVACY-ENHANCED MESSAGE-----